INS and diabetes mellitus: Recent studies have shown that combination therapies increase the levels of insulin and monoamines, reduce oxidative stress and production of proinflammatory cytokines, and can potentially be used to treat type 2 diabetes mellitus and co-morbid depression (Shivavedi et al., 2017).